ATE254177T1 - Staphylococcus aureus v8 protease mutanten - Google Patents

Staphylococcus aureus v8 protease mutanten

Info

Publication number
ATE254177T1
ATE254177T1 AT96303939T AT96303939T ATE254177T1 AT E254177 T1 ATE254177 T1 AT E254177T1 AT 96303939 T AT96303939 T AT 96303939T AT 96303939 T AT96303939 T AT 96303939T AT E254177 T1 ATE254177 T1 AT E254177T1
Authority
AT
Austria
Prior art keywords
urea
concentrations
enzyme
staphylococcus aureus
protease mutants
Prior art date
Application number
AT96303939T
Other languages
English (en)
Inventor
Masayuki Yabuta
Kazuhiro Ohsuye
Original Assignee
Daiichi Suntory Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Suntory Pharma Co Ltd filed Critical Daiichi Suntory Pharma Co Ltd
Application granted granted Critical
Publication of ATE254177T1 publication Critical patent/ATE254177T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT96303939T 1995-06-02 1996-05-31 Staphylococcus aureus v8 protease mutanten ATE254177T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17008695 1995-06-02

Publications (1)

Publication Number Publication Date
ATE254177T1 true ATE254177T1 (de) 2003-11-15

Family

ID=15898392

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96303939T ATE254177T1 (de) 1995-06-02 1996-05-31 Staphylococcus aureus v8 protease mutanten

Country Status (9)

Country Link
US (1) US5747321A (de)
EP (1) EP0745669B1 (de)
JP (1) JP3852982B2 (de)
KR (1) KR100650960B1 (de)
AT (1) ATE254177T1 (de)
DE (1) DE69630630T2 (de)
ES (1) ES2206546T3 (de)
HU (1) HUP9601487A3 (de)
IL (2) IL118473A0 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1090132A1 (de) * 1998-06-26 2001-04-11 PPL Therapeutics (Scotland) Limited Verfahren zur herstellung von rekombinanten polypetide
ES2401939T3 (es) 1999-07-23 2013-04-25 Kenji Kangawa Nuevos péptidos
US7217554B2 (en) * 1999-08-31 2007-05-15 Novozymes A/S Proteases and variants thereof
WO2001016285A2 (en) * 1999-08-31 2001-03-08 Novozymes A/S Novel proteases and variants thereof
US6558939B1 (en) * 1999-08-31 2003-05-06 Novozymes, A/S Proteases and variants thereof
ATE430799T1 (de) * 1999-10-19 2009-05-15 Bharat Biotech International L Expression von rekombinantem, reifem lysostaphin
CN100491395C (zh) 2002-04-11 2009-05-27 阿斯比奥制药株式会社 修饰肽的制造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69024261T2 (de) * 1989-05-24 1996-07-18 Merck & Co Inc Reinigung und Charakterisierung eines von einem Glioma abstammenden Wachstumsfaktors
US5536655A (en) * 1989-09-26 1996-07-16 Midwest Research Institute Gene coding for the E1 endoglucanase
ATE253639T1 (de) * 1991-08-19 2003-11-15 Daiichi Suntory Pharma Co Ltd Verfahren zur herstellung von peptiden

Also Published As

Publication number Publication date
ES2206546T3 (es) 2004-05-16
JPH0947291A (ja) 1997-02-18
IL118473A0 (en) 1996-09-12
DE69630630T2 (de) 2004-09-23
US5747321A (en) 1998-05-05
JP3852982B2 (ja) 2006-12-06
HU9601487D0 (en) 1996-08-28
EP0745669A3 (de) 1999-05-26
HUP9601487A3 (en) 2001-08-28
EP0745669B1 (de) 2003-11-12
IL118473A (en) 2005-03-20
DE69630630D1 (de) 2003-12-18
EP0745669A2 (de) 1996-12-04
KR970001536A (ko) 1997-01-24
HUP9601487A2 (en) 1997-05-28
KR100650960B1 (ko) 2007-03-02

Similar Documents

Publication Publication Date Title
Tokunaga et al. The factor V-activating enzyme (RVV-V) from Russell's viper venom. Identification of isoproteins RVV-V alpha,-V beta, and-V gamma and their complete amino acid sequences.
DE69628656D1 (de) Mannase von bacillus amyloliquefaciens und methode zu ihrer preparation
DE69434962D1 (de) Proteasehaltige reinigungsmittel
ATE203056T1 (de) Thermostabile dna polymerase aus thermoanaerobacter thermohydrosulfuricus und davon abgeleitete mutierte enzyme mit entfernter exonukleaseaktivität
DE60133802D1 (de) Verwendung von säurestabilen proteasen in tierfutter
ATE184289T1 (de) Ribosomen-inaktivierende proteine, inaktive vorläuferformen derselben, verfahren zur herstellung und eine methode zur nutzung
MXPA06001173A (es) Metodo analitico para la pancreatina y composiciones comparables.
ES2062812T3 (es) Composicion detergente enzimatica y metodo para estabilizar enzimas.
MA23330A1 (fr) Serine protease a absorption diminuee et hydrolyse accrue .
ATE94206T1 (de) Enzymhaltige zubereitung und eine solche zubereitung enthaltendes detergens.
DE69534467D1 (de) Modifikation des starke-gehalts in pflanzen
Cole et al. Purification and partial characterisation of a novel trypsin-like cysteine protease from Metarhizium anisopliae
SE8902532L (sv) Bestaemning av plasmaproteiner
DE69630630D1 (de) Staphylococcus aureus V8 Protease Mutanten
Huang et al. Formation of enzymatically active, homotypic, and heterotypic tetramers of mouse mast cell tryptases: dependence on a conserved Trp-rich domain on the surface
Sakharov et al. Purification and some properties of elastase from hepatopancreas of king crab Paralithodes camtschatica
FI934305A0 (fi) Dipeptidylaminopeptidas fraon dictyostelium
ES2134834T3 (es) Procedimiento para escindir proenzimas.
DE69736076D1 (de) Enzyme mit s-adenosyl-l-homocystein-hydrolase-ähnlicher aktivität.
Hayashi et al. Purification and characterization of two aminopeptidases produced by Brevibacterium linens
Gudzenko et al. Isolation and characterization of Bacillus sp. IMV B-7883 proteases
SE8502540D0 (sv) Stable dentifrice containing dextranase
Ansari et al. Purification and properties of two neutral proteinases from Aspergillus nidulans
FI925676A0 (fi) Vaermestabil proteas fraon staphylothermus
DK0667872T3 (da) Mutantinterleukin 6 med forbedret biologisk aktivitet i forhold til vildtype-interleukin 6

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0745669

Country of ref document: EP

EEIH Change in the person of patent owner